WO2018190481A1 - Procédé de rendu d'informations d'essai clinique dans un format d'examen médical entre des volontaires d'essai clinique et une institution médicale effectuant un essai clinique - Google Patents
Procédé de rendu d'informations d'essai clinique dans un format d'examen médical entre des volontaires d'essai clinique et une institution médicale effectuant un essai clinique Download PDFInfo
- Publication number
- WO2018190481A1 WO2018190481A1 PCT/KR2017/012107 KR2017012107W WO2018190481A1 WO 2018190481 A1 WO2018190481 A1 WO 2018190481A1 KR 2017012107 W KR2017012107 W KR 2017012107W WO 2018190481 A1 WO2018190481 A1 WO 2018190481A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- clinical trial
- information
- questionnaire
- volunteer
- clinical
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 29
- 238000009877 rendering Methods 0.000 title abstract 6
- 230000007115 recruitment Effects 0.000 claims abstract description 12
- 230000010354 integration Effects 0.000 claims abstract description 7
- 230000000391 smoking effect Effects 0.000 claims description 13
- 239000003814 drug Substances 0.000 claims description 12
- 238000012360 testing method Methods 0.000 claims description 10
- 230000035622 drinking Effects 0.000 claims description 9
- 206010020751 Hypersensitivity Diseases 0.000 claims description 8
- 208000026935 allergic disease Diseases 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 7
- 239000008280 blood Substances 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 5
- 235000006694 eating habits Nutrition 0.000 claims description 5
- 230000009610 hypersensitivity Effects 0.000 claims description 5
- 235000012054 meals Nutrition 0.000 claims description 5
- 230000007815 allergy Effects 0.000 claims description 3
- 238000012797 qualification Methods 0.000 claims description 3
- 238000011160 research Methods 0.000 claims description 3
- 230000000172 allergic effect Effects 0.000 claims description 2
- 208000010668 atopic eczema Diseases 0.000 claims description 2
- 235000013361 beverage Nutrition 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 238000011835 investigation Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 description 5
- 230000005540 biological transmission Effects 0.000 description 4
- 230000002124 endocrine Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000034578 Multiple myelomas Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 208000015634 Rectal Neoplasms Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 208000002154 non-small cell lung carcinoma Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 206010038038 rectal cancer Diseases 0.000 description 1
- 201000001275 rectum cancer Diseases 0.000 description 1
- 201000001244 rectum lymphoma Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000002105 tongue Anatomy 0.000 description 1
- 210000000515 tooth Anatomy 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/20—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
Definitions
- the present invention relates to a clinical trial information documenting technology, and more particularly, to a method of documenting clinical trial information between a clinical trial volunteer and a clinical trial administration medical institution online.
- the present invention has been made to solve the above problems of the prior art, clinical trial volunteers and clinicians who can quickly screen the qualified or ineligible subjects by digitizing the questionnaire information and clinical trial volunteer questionnaire information required for clinical trials
- the task is to provide a method for documenting the clinical trial information between the host medical institutions.
- the clinical trial questionnaire integrated server receives the clinical trial volunteer recruitment information from the clinical trial host medical institution to generate a common standard questionnaire by disease name and medical department, body parts and regions And transmitting and posting the clinical trial purpose, content, and qualification of the clinical trial volunteer notification information from the clinical trial document integration server to the clinical trial volunteer terminal on which the clinical trial support app is installed, and the clinical trial Sending a questionnaire integrated server to the clinical trial volunteer terminal, basic clinical information, physical information, and basic questionnaire about participation in a clinical trial by the clinical trial volunteer terminal; Receive the information entered about the basic questionnaire And generating the clinical trial questionnaire integrated server by comparing the reference questionnaire and the pre-test questionnaire to determine whether the clinical trial is eligible, and storing the clinical trial questionnaire integrated server in a database. And notifying the clinical trial volunteer terminal, and transmitting the qualified clinical trial volunteer information and the pre-test questionnaire to the clinical trial administration medical institution by the clinical trial questionnaire integrated server. Provide a method for documenting clinical trial information between medical institutions.
- the basic questionnaire is the blood type of the clinical trial volunteer, the past clinical trial participation experience, the participation in the clinical trial in the last three months, whether smoking, smoking, smoking, drinking, exercise, current disease, family history, drug Take-up, allergy / hypersensitivity, surgical experience, preference drink, hospital-supplied standard meals, and multiple-choice, short-term or multiple-choice questionnaire information about specific eating habits, and the reference questionnaire lists eligibility requirements for clinical trials.
- Blood type of clinical trial volunteers according to disease name, medical department, body part and region, history of past clinical trial participation, participation in clinical trial in the last 3 months, smoking status, smoking volume, drinking status, drinking volume, exercise status, current illness, Family history, drug use, allergies / hypersensitivity, surgical experience, preference drink, standard meals provided by hospital And it may include paperweight information about the specific eating habits.
- the method may further include transmitting the interview request information requested from the clinical study supervision medical institution to the qualified volunteer terminal.
- the method may further include generating an additional questionnaire requested by the clinical study supervision medical institution and providing it to the qualified volunteer terminal.
- the method may further include receiving the modified information received for the basic questionnaire from the clinical volunteer terminal and modifying the dictionary questionnaire.
- the most suitable clinical trial volunteers can be quickly selected. This can significantly reduce the number of people and costs involved in the clinical trial process.
- FIG. 1 is a schematic flowchart of a method for documenting clinical trial information between a clinical trial volunteer and a clinical trial administration medical institution according to a preferred embodiment of the present invention.
- FIG. 2 illustrates the photographic paperweight of FIG. 1.
- 3A to 3C illustrate the questionnaire information of FIG. 1 in detail.
- FIG. 1 is a schematic flowchart of a method for documenting clinical trial information between a clinical trial volunteer and a clinical institution administering a clinical trial according to a preferred embodiment of the present invention.
- FIG. 2 illustrates the photographic questionnaire of FIG. 1, and FIGS. 3A to 3C. Illustrates the paperweight information of FIG. 1 in detail.
- a reference questionnaire generation step (S110), clinical trial volunteer recruitment information posting step ( S120), the basic questionnaire transmission step (S130), the preliminary questionnaire generation step (S140), clinical trial eligibility determination step (S150), clinical trial eligibility notification step (S160) and clinical trial subject medical institution transmission step (S170) do.
- the clinical trial questionnaire integrated server 200 is notified of the recruitment of clinical trial volunteers from the clinical trial host medical institution (that is, pharmaceutical company, each medical group, medical institution or clinical trial conduct organization) (300)
- the information is transmitted to generate a common standard questionnaire by disease name, medical department, body part, and region (see FIG. 3).
- the reference questionnaire generation step (S110), cancer (detailed lung cancer, non-small cell lung cancer, adenocarcinoma, gastric cancer, breast cancer, rectal cancer, lymphoma or multiple myeloma), diabetes, arthritis, hepatitis, leukemia, hypertension, Alzheimer's disease, ulcer or asthma
- family medicine internal medicine (in detail, infectious medicine, endocrine medicine, endocrine metabolism or rheumatology), surgery, neurology, anesthesia and pain medicine, urology, radiology, gynecology, radiology, ophthalmology, otolaryngology, Head / face (eyes, ears, nose, teeth, mouth, tongue, gums or jaw), neck / chest, abdomen, pelvis, or other departments such as rehabilitation, mental health, dentistry, dermatology, pediatric adolescents or clinical pharmacology
- the body parts such as the arms / legs, it can be classified to generate the recruitment notification information of the clinical trial volunteers.
- the clinical trial volunteer recruitment notification information from the clinical trial documentation integrated server 200 to the clinical trial volunteer terminal 100 installed clinical trial support app, Send and post content and eligibility requirements.
- the clinical trial questionnaire integrated server 200 transmits the basic questionnaire information on the basic personal information, physical information and participation in the clinical trial of the clinical trial volunteer terminal 100 to the clinical trial volunteer terminal 100 do.
- basic personal information includes gender, age (date of birth), contact information (email or mobile phone), and local information (volunteer address).
- Physical information includes past and current medical history, weight, height, weight and height, BMI index, Blood type information (A, B, O or AB, and RH + or RH-), past clinical trial participation, past clinical trial participation in a specific time period or multiple choice questionnaire about smoking and drinking and smoking and drinking volume .
- the clinical trial questionnaire integrated server 200 receives the information received for the basic questionnaire from the clinical trial volunteer terminal 100 to generate a pre-test questionnaire (see Figure 2).
- receiving the modified information received for the basic questionnaire from the clinical trial volunteer terminal 100 may further comprise the step (S145) of modifying and generating a prior questionnaire.
- the clinical trial questionnaire integrated server 200 determines the clinical trial eligibility by comparing the aforementioned standard questionnaire table and the pre-test questionnaire. In this case, it is necessary to clearly determine whether the clinical trial is eligible or ineligible by filtering (screening) overlapping clinical trial support within a specific period by comparing and analyzing the standard questionnaire and the pre-test questionnaire.
- the basic questionnaire the blood type of the clinical trial volunteers, whether they have participated in past clinical trials, participation in clinical trials in the last three months, smoking, smoking, drinking, drinking, exercise, current illness, family history, drug use , Allergic / hypersensitivity, surgical experience, preference beverages, hospital provided standard meals and multiple choice (C), subjective (S) or multi-choice (M) questionnaire information for specific eating habits (Fig. 3a to Fig. 3c).
- the clinical trial document integration integrated server 200 stores the eligibility in a database, and sends it to the clinical trial volunteer terminal 100 by SNS, text or e-mail promptly do.
- the clinical trial documentization integrated server 200 quickly transmits the qualified clinical trial volunteer information and the pre-test questionnaire to the clinical trial subject medical institution 300 through SNS, text or e-mail. do.
- the additional questionnaire may include a detailed questionnaire questionnaire.
- the method may further include transmitting the interview request information requested from the clinical trial administration medical institution 300 to the qualified volunteer terminal 100 (S182).
- the clinical trial volunteer questionnaire information required in the clinical trial conducted by a pharmaceutical company, each medical group, a medical institution, or a clinical trial institute is digitized by the configuration of the clinical trial information documenting method as described above. You can quickly select the clinical trial volunteers that are best suited for your needs.
- the clinical trial support app is installed on the terminal, it can be equally applied to the clinical trial support service supported by the web service form, not the clinical trial support app.
- the clinical institution managing the study encompasses the relevant server of the clinical research institution or the terminal of the clinical research institution.
- the present invention is a clinical trial through the method of questionnaire between the clinical trial volunteer and the clinical institution in charge of the clinical trial that can quickly select the subject eligible or ineligible by digitizing the questionnaire and the clinical trial volunteer information required for the clinical trial It is very useful industrially because it can quickly select the most appropriate clinical trial volunteers and significantly reduce the manpower and costs involved in the clinical trial process.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Primary Health Care (AREA)
- Public Health (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
La présente invention concerne un procédé de rendu d'informations d'essai clinique dans un format d'examen médical entre des volontaires d'essai clinique et une institution médicale effectuant un essai clinique, comprenant les étapes consistant à : recevoir, en provenance de l'institution médicale effectuant un essai clinique, des informations de notification de recrutement de volontaire d'essai clinique et générer un tableau d'examen médical de référence ; transmettre et publier des informations de notification de recrutement de volontaire d'essai clinique en provenance d'un serveur d'intégration de rendu d'examen médical d'essai clinique vers un terminal d'un volontaire d'essai clinique sur lequel a été installée une application d'inscription à un essai clinique ; transmettre, au moyen du serveur d'intégration de rendu d'examen médical d'essai clinique, au terminal du volontaire d'essai clinique, un tableau d'examen médical de base comprenant des informations d'identification de base, des informations physiques et une décision de participation à l'essai clinique ; recevoir, au moyen du serveur d'intégration de rendu d'examen médical d'essai clinique, en provenance du terminal du volontaire d'essai clinique, des informations saisies concernant le tableau d'examen médical de base et générer un tableau d'examen médical de pré-visite ; comparer, au moyen du serveur d'intégration de rendu d'examen médical d'essai clinique, le tableau d'examen médical de base et le tableau d'examen médical de pré-visite et déterminer l'éligibilité pour l'essai clinique ; et notifier par l'intermédiaire du terminal du volontaire d'essai clinique, ce qui permet une sélection rapide de candidats optimaux pour l'essai clinique parmi les participants d'essai clinique éligibles en utilisant des informations de tableau d'examen médical numérisées.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170046919 | 2017-04-11 | ||
KR10-2017-0046919 | 2017-04-11 | ||
KR10-2017-0086259 | 2017-07-07 | ||
KR1020170086259A KR20180121765A (ko) | 2017-04-11 | 2017-07-07 | 임상시험 자원자와 임상시험 주관의료기관 간의 임상시험정보 문진화 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018190481A1 true WO2018190481A1 (fr) | 2018-10-18 |
Family
ID=63793319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2017/012107 WO2018190481A1 (fr) | 2017-04-11 | 2017-10-30 | Procédé de rendu d'informations d'essai clinique dans un format d'examen médical entre des volontaires d'essai clinique et une institution médicale effectuant un essai clinique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018190481A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099570A1 (en) * | 2000-08-24 | 2002-07-25 | Knight Stephen C. | Recruiting a patient into a clinical trial |
US20060149602A1 (en) * | 2003-05-14 | 2006-07-06 | Clinilabs, Inc. | Methods and systems for online clinical trial screening |
KR20100038623A (ko) * | 2008-10-06 | 2010-04-15 | 주식회사 더마프로 | 임상 피험자 모집 시스템 및 방법 |
JP2011233066A (ja) * | 2010-04-30 | 2011-11-17 | Huma Corp | 被験者募集方法、仲介者のサーバ、ソフトウェア、記録媒体 |
US20140303999A1 (en) * | 2011-11-07 | 2014-10-09 | Mitchell D. Efros | Method for creating and using registry of clinical trial participants |
-
2017
- 2017-10-30 WO PCT/KR2017/012107 patent/WO2018190481A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020099570A1 (en) * | 2000-08-24 | 2002-07-25 | Knight Stephen C. | Recruiting a patient into a clinical trial |
US20060149602A1 (en) * | 2003-05-14 | 2006-07-06 | Clinilabs, Inc. | Methods and systems for online clinical trial screening |
KR20100038623A (ko) * | 2008-10-06 | 2010-04-15 | 주식회사 더마프로 | 임상 피험자 모집 시스템 및 방법 |
JP2011233066A (ja) * | 2010-04-30 | 2011-11-17 | Huma Corp | 被験者募集方法、仲介者のサーバ、ソフトウェア、記録媒体 |
US20140303999A1 (en) * | 2011-11-07 | 2014-10-09 | Mitchell D. Efros | Method for creating and using registry of clinical trial participants |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kypri et al. | Randomized controlled trial of web-based alcohol screening and brief intervention in primary care | |
Schroeder | Western European responses to physician oversupply: lessons for the United States | |
Treloar et al. | Health literacy in relation to cancer: addressing the silence about and absence of cancer discussion among a boriginal people, communities and health services | |
Fitch et al. | Challenges having conversations about sexuality in ambulatory settings: Part II— Health care provider perspectives | |
Guo et al. | Exploration of interventions to enhance return-to-work for cancer patients: a scoping review | |
Smith et al. | Enhancing the informed consent process for critical care research: strategies from a thromboprophylaxis trial | |
Pierre Joseph et al. | Ethnic differences in perceived benefits and barriers to HPV vaccine acceptance: a qualitative analysis of young African American, Haitian, Caucasian, and Latino men | |
Pearson et al. | Access to and engagement with cervical and breast screening services for women with disabilities in Aotearoa New Zealand | |
Atta et al. | Characteristics associated with barriers to eye care: a cross-sectional survey at a free vision screening event | |
Anderson et al. | Personalized follow-up increases return rate at urban eye disease screening clinics for African Americans with diabetes | |
Senderovich et al. | COVID-19 virtual care for the geriatric population: exploring two sides of the coin | |
Zaitoun et al. | Audiology practice during COVID-19 crisis in Jordan and Arab countries | |
Micallef et al. | Telehealth outpatient coronavirus disease 2019 case management at a tertiary hospital in Sydney | |
Tan et al. | Effectiveness of mHealth-based psychosocial interventions for breast cancer patients and their caregivers: A systematic review and meta-analysis | |
Darici et al. | Are stereotypes in decline? The portrayal of female anatomy in e‐learning | |
LA FAUCI et al. | Health literacy in Mediterranean general population | |
Peters | Reasons why women choose a medical practice or a women’s health centre for routine health screening: worker and client perspectives | |
Salisu et al. | Community perceptions of health equity: a qualitative study | |
Buzaglo et al. | An Internet method to assess cancer patient information needs and enhance doctor-patient communication: a pilot study | |
Tang et al. | Knowledge, attitudes, and practice patterns relating to sexual dysfunction among urologists and andrologists in China | |
WO2018190481A1 (fr) | Procédé de rendu d'informations d'essai clinique dans un format d'examen médical entre des volontaires d'essai clinique et une institution médicale effectuant un essai clinique | |
Hutchinson et al. | How the philosophies, styles, and methods of family medicine affect the research agenda | |
Al-Rayes et al. | Public awareness and use of health tools provided by the portal of the Ministry of Health of Saudi Arabia | |
Stryer et al. | Reducing racial and ethnic disparities in health care | |
WO2018190480A1 (fr) | Système de mise en correspondance d'informations d'essai clinique entre des volontaires d'essai clinique et une institution médicale conduisant un essai clinique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17905135 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17905135 Country of ref document: EP Kind code of ref document: A1 |